India waives local trials for select foreign-approved drugs

India's Central Government has waived local clinical trial requirements for drugs approved in the US, UK, Japan, Australia, Canada, and the EU. This applies to orphan drugs, gene therapies, pandemic-related drugs, and those with significant therapeutic advances. The decision, announced on August 7, aims to improve drug accessibility and affordability in India, responding to long-standing demands from pharmaceutical companies and health experts.